Search Results
Advantages & concerns associated with the use of ADC-based conditioning in SCT recipients
LBA: CD33 CRISPR/Cas9 gene-edited donor allograft in patients with AML at risk of relapse post-HSCT
The impact of the tumor microenvironment on patient outcomes and BTKi resistance in MCL
What are the possible side effects of immune therapies for acute myeloid leukemia?
Virtual Patient Conference: Sezary Syndrome
Part 3 - Update on stem cell transplant in Lymphoma - Dr Hari Parameswaran, USA
Acalabrutinib and rituximab as first-line therapy for older patients with MCL
IMF Virtual Regional Community Workshop (RCW) - New England
2024 PAOLA CAMPESE AWARD SYMPOSIUM
CAR T-Cell Therapy: It's Role after Transplant 2021
EATx HYBRID ‘Imaging techniques and clinical applications’ 1 March 2021
WSCS16 - Day 4 - Immuno-Oncology Update: State of the Art
